Tower Research Capital (TRC)’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,171
| Closed | -$3K | – | 4817 |
|
|
2019
Q3 | $3K | Buy |
+1,171
| New | +$3K | ﹤0.01% | 3634 |
|
|
2019
Q2 | – | Sell |
-1,652
| Closed | -$5K | – | 4653 |
|
|
2019
Q1 | $5K | Sell |
1,652
-661
| -29% | -$2K | ﹤0.01% | 3125 |
|
|
2018
Q4 | $6K | Buy |
2,313
+930
| +67% | +$2.41K | ﹤0.01% | 2856 |
|
|
2018
Q3 | $6K | Buy |
+1,383
| New | +$6K | ﹤0.01% | 3079 |
|
|
2017
Q2 | – | Sell |
-2,593
| Closed | -$10K | – | 3912 |
|
|
2017
Q1 | $10K | Buy |
2,593
+1,562
| +152% | +$6.02K | ﹤0.01% | 1805 |
|
|
2016
Q4 | $4K | Sell |
1,031
-226
| -18% | -$877 | ﹤0.01% | 3194 |
|
|
2016
Q3 | $4K | Buy |
1,257
+757
| +151% | +$2.41K | ﹤0.01% | 2761 |
|
|
2016
Q2 | $3K | Sell |
500
-1,342
| -73% | -$8.05K | ﹤0.01% | 3787 |
|
|
2016
Q1 | $7K | Buy |
1,842
+1,301
| +240% | +$4.94K | ﹤0.01% | 2446 |
|
|
2015
Q4 | $4K | Sell |
541
-876
| -62% | -$6.48K | ﹤0.01% | 3310 |
|
|
2015
Q3 | $11K | Sell |
1,417
-3,679
| -72% | -$28.6K | ﹤0.01% | 2269 |
|
|
2015
Q2 | $48K | Buy |
5,096
+996
| +24% | +$9.38K | ﹤0.01% | 1403 |
|
|
2015
Q1 | $38K | Sell |
4,100
-1,333
| -25% | -$12.4K | ﹤0.01% | 1711 |
|
|
2014
Q4 | $51K | Buy |
5,433
+2,065
| +61% | +$19.4K | ﹤0.01% | 1026 |
|
|
2014
Q3 | $34K | Buy |
3,368
+34
| +1% | +$343 | ﹤0.01% | 1872 |
|
|
2014
Q2 | $28K | Buy |
3,334
+2,034
| +156% | +$17.1K | ﹤0.01% | 1647 |
|
|
2014
Q1 | $12K | Buy |
1,300
+800
| +160% | +$7.39K | ﹤0.01% | 2460 |
|
|
2013
Q4 | $3K | Sell |
500
-1,558
| -76% | -$9.35K | ﹤0.01% | 3903 |
|
|
2013
Q3 | $7K | Buy |
+2,058
| New | +$7K | ﹤0.01% | 3484 |
|